Qube Research & Technologies (QRT)’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.4M | Buy |
3,089,771
+1,245,188
| +68% | +$5.82M | 0.01% | 773 |
|
2025
Q1 | $10.1M | Buy |
1,844,583
+1,384,975
| +301% | +$7.6M | 0.01% | 861 |
|
2024
Q4 | $1.56M | Buy |
459,608
+218,037
| +90% | +$739K | ﹤0.01% | 1576 |
|
2024
Q3 | $688K | Buy |
241,571
+217,668
| +911% | +$620K | ﹤0.01% | 1792 |
|
2024
Q2 | $53.8K | Sell |
23,903
-154,659
| -87% | -$348K | ﹤0.01% | 2359 |
|
2024
Q1 | $395K | Buy |
+178,562
| New | +$395K | ﹤0.01% | 2270 |
|
2023
Q4 | – | Sell |
-53,883
| Closed | -$100K | – | 4248 |
|
2023
Q3 | $100K | Buy |
+53,883
| New | +$100K | ﹤0.01% | 2230 |
|
2022
Q3 | – | Sell |
-196,528
| Closed | -$303K | – | 3057 |
|
2022
Q2 | $303K | Buy |
196,528
+100,906
| +106% | +$156K | ﹤0.01% | 1577 |
|
2022
Q1 | $245K | Sell |
95,622
-26,005
| -21% | -$66.6K | ﹤0.01% | 1856 |
|
2021
Q4 | $356K | Buy |
+121,627
| New | +$356K | ﹤0.01% | 1720 |
|